Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 0.5300
-0.0150 (-2.75%)
Sep 24, 2026, 5:24 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 1.51 million as of September 24, 2026. Its market cap has decreased by -98.72% in one year.
Market Cap
1.51M
Enterprise Value
-1.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
ChartMarket Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 1.51M, a decrease of -99.24%. That is a compound annual growth rate of -60.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 1.51M | -98.38% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 71.65M |
| AcouSort AB | 65.82M |
| Modus Therapeutics Holding AB | 58.74M |
| OncoZenge AB | 46.64M |
| Fluicell AB | 41.76M |
| ExpreS2ion Biotech Holding AB | 28.62M |
| Magle Chemoswed Holding AB | 21.18M |
| Alligator Bioscience AB | 13.32M |